Use Of Edg Receptor Binding Agents In Cancer


The full document isn't yet available to us from the patent office.


Provided is a method for treating solid tumors, e.g tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 16, 2008
  • Application: May 15, 2003
    EP EP 08152489 A
  • Priority: May 15, 2003
    EP EP 03730049 A
  • Priority: Feb 24, 2003
    US US 44973903 P
  • Priority: Jul 24, 2002
    GB GB 0217150 A
  • Priority: Jun 20, 2002
    US US 39041102 P
  • Priority: May 16, 2002
    GB GB 0211261 A

Download Citation

Sign in to the Lens